Changes to MBS items 15900 and 31516 factsheet

1 March changes to MBS items 15900 and 31516

Page last updated: 28 January 2021

From 1 March 2021, Medicare Benefits Schedule (MBS) items 15900 and 31516 for Targeted Intraoperative Radiotherapy (T-IORT) are changing to include services delivered using the Xoft® Axxent® (California, USA) device.

The change was recommended by the Medical Services Advisory Committee (MSAC) after consideration of the clinical evidence, cost-effectiveness and safety of the procedures.

These changes are relevant for all specialists involved in delivery of T-IORT for early stage breast cancer.

PDF Version Factrsheet Changes to MBS items 15900 and 31516 for T-IORT (PDF 181 KB)

Word Version Factrsheet Changes to MBS items 15900 and 31516 for T-IORT (Word 81 KB)

In this section